Cargando…
Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge
BACKGROUND: Bile salts likely contribute to liver injury in patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). Fibroblast growth factor 19 (FGF19) is a bile salt-induced enterokine with hepatoprotective potential as it suppresses de novo bile salt synthesis. He...
Autores principales: | Zweers, Serge J., de Vries, Elisabeth M., Lenicek, Martin, Tolenaars, Dagmar, de Waart, D. Rudi, Koelfat, Kiran V. K., Groen, Albert K., Olde Damink, Steven W. M., Beuers, Ulrich, Ponsioen, Cyriel, Jansen, Peter L. M., Schaap, Frank G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233735/ https://www.ncbi.nlm.nih.gov/pubmed/27696157 http://dx.doi.org/10.1007/s12072-016-9769-7 |
Ejemplares similares
-
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
por: de Vries, Elisabeth M, et al.
Publicado: (2018) -
The Simple Cholestatic Complaints Score is a valid and quick patient‐reported outcome measure in primary sclerosing cholangitis
por: van Munster, Kim N., et al.
Publicado: (2020) -
Primary Sclerosing Cholangitis With Features of Autoimmune Hepatitis: Exploring the Global Variation in Management
por: Milkiewicz, Piotr, et al.
Publicado: (2020) -
Primary Sclerosing Cholangitis–Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
por: Kamp, Eline J.C.A., et al.
Publicado: (2021) -
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis
por: Kamp, Eline JCA, et al.
Publicado: (2022)